Abstract:The translocation t(8;21) (q22;q22) frequently associated with additional chromosomal aberrations is one of the most recurrent chromosomal abnormalities in AML. Clinically, this type of AML usually shows some specific characteristics and has a good response to chemotherapy with a high remission rate and a relatively long median survival.On the other hand, some reports also showed poor prognosis in AML patients with t(8;21 ) , and the associated bad prognosis factors have not been strongly established to date. To investigate this issue and to further identify the related characteristics of t(8 ;21 ) AML in China, 75 Chinese AML patients with t(8 ;21 ) were retrospectively analyzed. They comprised 68 cases of M2, five of M4 and two of M5 according to FAB classification. The results indicated that Auer rods were observed in 39 patients (52%) and marrow eosinophilia was detected in only 5 patients (6.7%). These patients showed high level of HLA-DR and CD34 expression, while CD19 was detected in only 13 patients (20.9%). Cytogenetically, 62.5 % cases had additional chromosomal abnormalities, and the main associated recurrent additional abnormalities were loss of a sex chromosome (LOS), trisomy 4, del (9q) and trisomy 8. After conventional induction therapy, 62 patients attained complete remission (CR) resulting in the CR rate 82.7%. With a follow-up of 1 to 96 months, 19 cases relapsed at a median time of 10.5 months (range 3 to 42 months). The median overall survival was 20 months, and the estimated 5-year overall survival (OS) rate was 32.3%. In multivariate analyses of prognostic factors,karyotype, extramedullary leukemia, age and post-remission therapy were of prognostic value for OS. Patients with additional chromosomal anomalies had shorter survival compared to those with t(8 ;21 ) only (P = 0.019), no matter which kind of additional karyotype it was. Extramedullary leukemia was an adverse prognostic factor ( P = 0. 012). Patients aged 15 years or less had a longer survival than those aged more than 15 years (P =0.045). Patients accepted HSCT in post-remission therapy had better outcome compared to those with chemotherapy only. It is concluded that Chinese AML patients with t(8 ;21 ) had some different characteristics as compared with patients from other countries, a relatively poor outcome was observed in our patients, especially in those with extramedullary leukemia or additional chromosomal abnormalities. HSCT should be recommended to t(8 ;21 ) AML in China, especially to those with adverse prognostic factors.

Comprehensive profile of cytogenetics in 2308 Chinese children and adults with de novo acute myeloid leukemia.

Cytogenetic Profile of De Novo Acute Myeloid Leukemia: a Study Based on 1432 Patients in a Single Institution of China

Cytogenetic Analysis of 1863 Chineses Patients with Chronic Myeloid Leukemia

Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population

[Cytogenetic and Molecular Analysis of 1193 Cases with Chronic Myeloid Leukemia].

[Cytogenetic Analysis of 154 Case of Acute Myeloid Leukemia with T(8;21)].

FLT3 and NPM1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Normal Cytogenetics

Clinical Significance of Cytogenetic and Molecular Genetic Abnormalities in 634 Chinese Patients with Myelodysplastic Syndromes

Unusual Findings Of Acute Myeloid Leukemia With Inv(3)(Q21q26.2) Or T(3;3)(Q21;Q26.2): A Multicenter Study

MicroRNA Expression Profiles in Acute Myeloid Leukemia with Common Translocations.

A Comprehensive Cytogenetic Classification Of 1466 Chinese Patients With De Novo Acute Lymphoblastic Leukemia

Cytogenetic and Molecular Features of 1331 Chinese Patients with Primary Acute Lymphoblastic Leukemia (ALL).

Clinical features and long-term outcomes of pediatric patients with de novo acute myeloid leukemia in China with or without specific gene abnormalities: a cohort study of patients treated with BCH-AML 2005

Cytogenetic Characteristics of Childhood Acute Lymphoblastic Leukemia: A Study of 1541 Chinese Patients Newly Diagnosed Between 2001 and 2014

The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China

Newly Diagnosed Acute Lymphoblastic Leukemia in China (I): Abnormal Genetic Patterns in 1346 Childhood and Adult Cases and Their Comparison with the Reports from Western Countries

Cytogenetic characteristics and clinical outcome of t(8;21) childhood acute myeloid leukemia

Characteristics and Prognostic Factors of Acute Myeloid Leukemia with T( 8 ;21 ) ( Q22; Q22)

[Analysis of Age-Specific Cytogenetic Changes among 515 Patients Withacute Myeloid Leukemia].

Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification

Prospective Study of 174 De Novo Acute Myelogenous Leukemias According to the WHO Classification: Subtypes, Cytogenetic Features and FLT3 Mutations.